Xtant Medical Holdings, Inc (XTNT) insider trading
Every open-market stock purchase and sale by Xtant Medical Holdings, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Kevin D Brandt (C-suite exec), $49.8K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.33 on Aug 20, 2026.
Recent XTNT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 15, 2026 | Scott C Neils (CFO) | Sold (not open market) | $8.7K |
| Aug 15, 2026 | Sean E Browne (CEO) | Sold (not open market) | $3.3K |
| Aug 15, 2026 | Mark A. Schallenberger (COO) | Sold (not open market) | $2.2K |
| Aug 15, 2026 | John K Bakewell (Director) | Bought (not open market) | — |
| Aug 15, 2026 | Sean E Browne (CEO) | Bought (not open market) | — |
| Aug 15, 2026 | Stavros G. Vizirgianakis (Director) | Bought (not open market) | — |
| Aug 15, 2026 | Abhinav Jain (Director) | Bought (not open market) | — |
| Aug 15, 2026 | Tyler Lipschultz (Director) | Bought (not open market) | — |
| Aug 15, 2026 | Mark A. Schallenberger (COO) | Bought (not open market) | — |
| Aug 15, 2026 | Jonn R. Beeson (Director) | Bought (not open market) | — |
| Aug 15, 2026 | Scott C Neils (CFO) | Bought (not open market) | — |
| Feb 15, 2026 | Mark A. Schallenberger (COO) | Sold (not open market) | $4.5K |
| Jan 15, 2026 | Scott C Neils (CFO) | Sold (not open market) | $5.3K |
| Nov 15, 2025 | Sean E Browne (CEO) | Bought (not open market) | — |
| Nov 15, 2025 | Scott C Neils (CFO) | Bought (not open market) | — |
| Nov 15, 2025 | Abhinav Jain (Director) | Bought (not open market) | — |
| Nov 15, 2025 | Stavros G. Vizirgianakis (Director) | Bought (not open market) | — |
| Nov 15, 2025 | Jonn R. Beeson (Director) | Bought (not open market) | — |
| Nov 15, 2025 | Tyler Lipschultz (Director) | Bought (not open market) | — |
| Nov 15, 2025 | John K Bakewell (Director) | Bought (not open market) | — |
| Nov 15, 2025 | Sean E Browne (CEO) | Bought (not open market) | — |
| Nov 15, 2025 | John K Bakewell (Director) | Bought (not open market) | — |
| Nov 15, 2025 | Mark A. Schallenberger (COO) | Bought (not open market) | — |
| Nov 15, 2025 | Mark A. Schallenberger (COO) | Bought (not open market) | — |
| Nov 15, 2025 | Scott C Neils (CFO) | Bought (not open market) | — |
Who's trading XTNT
- John K Bakewell, Director: other filings, last Aug 15, 2026
- Jonn R. Beeson, Director: other filings, last Aug 15, 2026
- Tyler Lipschultz, Director: other filings, last Aug 15, 2026
- Scott C Neils, CFO: other filings, last Aug 15, 2026
- Mark A. Schallenberger, COO: other filings, last Aug 15, 2026
- Stavros G. Vizirgianakis, Director: other filings, last Aug 15, 2026
- Sean E Browne, CEO: other filings, last Aug 15, 2026
- Abhinav Jain, Director: other filings, last Aug 15, 2026
Get free alerts when an insider at Xtant Medical Holdings, Inc files a new trade →